0
<

AVELOX MOXIFLOXACIN IV 400mg * 250ml

Avelox Moxifloxacin IV is indicated for the treatment of sinus and lung infections such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. It is also used for the treatment of bacterial conjunctivitis (pinkeye). Avelox IV contains the active ingredient, moxifloxacin, which is an antibiotic belonging to a group of medicines called fluoroquinolones. These antibiotics work by killing the bacteria that are causing your infection.

KES 4,056.00

(Inclusive of all taxes)

  • No Warranty

  • COD Avilable

  • Non Returnable

  • Non cancelable

About this item

Brand Name: La Roche


INDICATION AND DOSAGE Avelox Moxifloxacin IV is a sterile intravenous antibiotic used in adults for the treatment of infections of the lungs, airways and sinuses such as sinusitis, pneumonia, and secondary infections in chronic bronchitis. Avelox Moxifloxacin????? IV can also be used to treat severe and complicated skin and skin structure infections, and complicated infections within the abdomen as well as ?????for the treatment of bacterial conjunctivitis (pinkeye). Avelox IV contains the active ingredient, moxifloxacin, which is an antibiotic belonging to a group of medicines called fluoroquinolones. These antibiotics work by killing the bacteria that are causing your infection. RECOMMENDED DOSAGE This depends on your condition, and will be prescribed by your doctor. The usual adult dose is 400mg once a day for 7-14 days. Avelox IV is given as a slow injection into a vein, over a period of 60 minutes (??????drip??????). Avelox IV must only be given by a doctor or a nurse. PREGNANCY AND LACTATION The medication is not recommended during pregnancy and breastfeeding. A physician consultation is highly recommended in such cases. SIDE EFFECTS headache, dizziness, vomiting, nausea, stomach pain diarrhea, thrush in the mouth ACTIVE INGREDIENT Moxifloxacin hydrochloride

No Reviews
AVELOX MOXIFLOXACIN IV 400mg * 250ml

No Faq

No FAQs Found

WhatsApp
Forgot Password?
OR

No account Yet?